Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 5.91% is 171% above its 5-year average of -8.30%, near the high end of its 5-year range (-28.34%–5.91%).
334.56% above its 12-month average of 1.36%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): 2.72%.
RETURN ON ASSETS (ROA)
5.91%
RETURN ON ASSETS (ROA) AVG TTM
1.36%
RETURN ON ASSETS (ROA) AVG 3Y
-4.42%
RETURN ON ASSETS (ROA) AVG 5Y
-8.30%
RETURN ON ASSETS (ROA) AVG 10Y
1.72%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+334.56%
CURRENT VS 3Y AVG
+233.71%
CURRENT VS 5Y AVG
+171.18%
CURRENT VS 10Y AVG
+244.33%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-29.61%
median of 622 covered companies
CURRENT VS SECTOR MEDIAN
+119.96%
vs the sector median at left
Cronos Group Inc.
Market Cap
$1.21B
Return on Assets (ROA)
5.91%
TTM Avg
1.36%
3Y Avg
-4.42%
5Y Avg
-8.30%
Market Cap
$1.21B
Return on Assets (ROA)
1.31%
TTM Avg
-17.71%
3Y Avg
-26.67%
5Y Avg
-26.67%
Market Cap
$1.21B
Return on Assets (ROA)
-0.46%
TTM Avg
-2.95%
3Y Avg
-4.25%
5Y Avg
-4.39%
Market Cap
$1.19B
Return on Assets (ROA)
-5.96%
TTM Avg
3.87%
3Y Avg
-6.09%
5Y Avg
-17.05%
Market Cap
$1.19B
Return on Assets (ROA)
-49.10%
TTM Avg
-49.10%
3Y Avg
-49.10%
5Y Avg
-49.10%
Market Cap
$1.17B
Return on Assets (ROA)
-14.35%
TTM Avg
-48.83%
3Y Avg
-54.71%
5Y Avg
-49.10%
Market Cap
$1.16B
Return on Assets (ROA)
0.69%
TTM Avg
1.67%
3Y Avg
0.18%
5Y Avg
-3.47%
Market Cap
$1.14B
Return on Assets (ROA)
-3.98%
TTM Avg
-7.05%
3Y Avg
-9.66%
5Y Avg
-6.44%
Market Cap
$1.13B
Return on Assets (ROA)
-57.23%
TTM Avg
-57.23%
3Y Avg
-57.23%
5Y Avg
-57.23%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.21B | 5.91% | 1.36% | -4.42% | -8.30% |
| Omada Health (OMDA)vs › | $1.21B | 1.31% | -17.71% | -26.67% | -26.67% |
| Innovage Holding Corp. (INNV)vs › | $1.21B | -0.46% | -2.95% | -4.25% | -4.39% |
| MannKind Corporation (MNKD)vs › | $1.19B | -5.96% | 3.87% | -6.09% | -17.05% |
| Kardigan, Inc. (KARD)vs › | $1.19B | -49.10% | -49.10% | -49.10% | -49.10% |
| Nektar Therapeutics (NKTR)vs › | $1.17B | -14.35% | -48.83% | -54.71% | -49.10% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.16B | 0.69% | 1.67% | 0.18% | -3.47% |
| OPKO Health, Inc. (OPK)vs › | $1.14B | -3.98% | -7.05% | -9.66% | -6.44% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -57.23% | -57.23% | -57.23% | -57.23% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.13B | -48.35% | -102.84% | -97.55% | -75.48% |
ROA
5.9%
ROE
6.5%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.80% |
| 2024-12-31 | 3.52% |
| 2023-12-31 | -6.49% |
| 2022-12-31 | -13.91% |
| 2021-12-31 | -28.34% |
| 2020-12-31 | -3.80% |
| 2019-12-31 | 76.02% |
| 2018-12-31 | -9.33% |
| 2017-12-31 | 3.15% |
| 2016-12-31 | -3.76% |
| 2015-12-31 | 2.62% |
| 2014-12-31 | -48.43% |
| 2013-12-31 | -2.09% |
| 2013-03-31 | 0.00% |
